Charles A. Deignan
CIK 1664690 · Chief Financial Officer · last filed 2025-01-10
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
1
Total Filings
26
Lifetime Open-Market Net
-$79.9K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Clearside Biomedical, Inc. (CLSD) Delisted | Chief Financial Officer | 384,662 | $0.35 | $135.2K | -$79.9K | 26 | 2025-01-10 |
Recent Filings · Page 3 of 3
26 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-12-12 | Clearside Biomedical, Inc. (CLSD) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-08-14 | Clearside Biomedical, Inc. (CLSD) Delisted | Buy (P) | +1,000 | $7.1K | EDGAR |
| 2017-07-05 | Clearside Biomedical, Inc. (CLSD) Delisted | Grant (A) | +1,550 | $12.0K | EDGAR |
| 2016-12-19 | Clearside Biomedical, Inc. (CLSD) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-07-25 | Clearside Biomedical, Inc. (CLSD) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-06-07 | Clearside Biomedical, Inc. (CLSD) Delisted | Mixed | +4,729 | -$4 | EDGAR |
Showing 21–26 of 26
Prev
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.